The DEA Is Getting Past Just Saying No: Scientific Research Into Medical Uses of Marijuana Is a Bridge Toward a Policy Shift
David Spellman and Justin Hobson co-authored an article titled “The DEA Is Getting Past Just Saying No: Scientific Research Into Medical Uses of Marijuana Is a Bridge Toward a Policy Shift.” The article discusses the U.S. Drug Enforcement Agency (DEA)’s recent decision to decline rescheduling cannabis, which has left federal agencies calling for more research into the medical uses of marijuana and could serve as a bridge toward a policy shift.
The DEA Is Getting Past Just Saying No. Reading the DEA’s recent “Denial of Petition to Initiate Proceedings to Reschedule Marijuana” calls to mind Ury’s book, “Getting Past No: Negotiating with Difficult People.” The book offers strategies for those who are disappointed with the DEA’s decision — don’t react, disarm them, change the game and make it easier to say yes and more difficult to say no. Those strategies might have softened some of the visceral reactions in the last few days. Yet, the FDA and Department of Health and Human Services (HHS) are already changing the game by opening the dialogue about medical research, getting past no on a national level.